LT2567976T - Antikūnai prieš cd38 antigeną, skirti daugybinės mielomos gydymui - Google Patents

Antikūnai prieš cd38 antigeną, skirti daugybinės mielomos gydymui

Info

Publication number
LT2567976T
LT2567976T LTEP12178778.2T LT12178778T LT2567976T LT 2567976 T LT2567976 T LT 2567976T LT 12178778 T LT12178778 T LT 12178778T LT 2567976 T LT2567976 T LT 2567976T
Authority
LT
Lithuania
Prior art keywords
treatment
antibodies against
multiple myeloma
myeloma
antibodies
Prior art date
Application number
LTEP12178778.2T
Other languages
English (en)
Lithuanian (lt)
Inventor
Yvo Graus
Paul Parren
Jan Van De Winkel
Michel De Weers
Judith Oprins
Martine Van Vugt
Original Assignee
Genmab A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genmab A/S filed Critical Genmab A/S
Publication of LT2567976T publication Critical patent/LT2567976T/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
LTEP12178778.2T 2005-03-23 2006-03-23 Antikūnai prieš cd38 antigeną, skirti daugybinės mielomos gydymui LT2567976T (lt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200500429 2005-03-23
US66757905P 2005-04-01 2005-04-01
US69616305P 2005-07-01 2005-07-01
US72856105P 2005-10-20 2005-10-20

Publications (1)

Publication Number Publication Date
LT2567976T true LT2567976T (lt) 2017-12-11

Family

ID=50644285

Family Applications (2)

Application Number Title Priority Date Filing Date
LTEP12178778.2T LT2567976T (lt) 2005-03-23 2006-03-23 Antikūnai prieš cd38 antigeną, skirti daugybinės mielomos gydymui
LTEP06722861.9T LT1866338T (lt) 2005-03-23 2006-03-23 Antikūnai prieš cd38, skirti daugybinės mielomos gydymui

Family Applications After (1)

Application Number Title Priority Date Filing Date
LTEP06722861.9T LT1866338T (lt) 2005-03-23 2006-03-23 Antikūnai prieš cd38, skirti daugybinės mielomos gydymui

Country Status (12)

Country Link
KR (1) KR20140033240A (enExample)
BE (1) BE2017C062I2 (enExample)
DK (1) DK1866338T3 (enExample)
ES (2) ES2644982T3 (enExample)
HU (2) HUE030783T2 (enExample)
LT (2) LT2567976T (enExample)
NZ (2) NZ600059A (enExample)
PL (1) PL1866338T3 (enExample)
PT (2) PT2567976T (enExample)
RS (1) RS55442B1 (enExample)
SG (1) SG10201610317VA (enExample)
UA (2) UA98756C2 (enExample)

Also Published As

Publication number Publication date
ES2606762T3 (es) 2017-03-27
KR20140033240A (ko) 2014-03-17
NZ625944A (en) 2016-01-29
UA98756C2 (ru) 2012-06-25
RS55442B1 (sr) 2017-04-28
DK1866338T3 (da) 2017-01-02
HUE030783T2 (en) 2017-06-28
HUE034962T2 (en) 2018-03-28
BE2017C062I2 (enExample) 2025-12-03
LT1866338T (lt) 2017-01-25
SG10201610317VA (en) 2017-02-27
PL1866338T3 (pl) 2017-04-28
UA116520C2 (uk) 2018-04-10
PT1866338T (pt) 2016-12-14
PT2567976T (pt) 2017-10-19
ES2644982T3 (es) 2017-12-01
NZ600059A (en) 2016-01-29

Similar Documents

Publication Publication Date Title
IL304150A (en) Antibodies against 38cd for the treatment of multiple myeloma
HRP20181565T1 (hr) Monoklonska protutijela protiv klaudina-18 za liječenje karcinoma
SI2029155T1 (sl) Izboljšano zdravljenje multiplega mieloma
IL243687A0 (en) For the treatment of multiple myeloma 1–cs antibodies against
PT1962913E (pt) Radioimunoconjugado para cd66 humano para o tratamento de mieloma múltiplo
HUS1700054I1 (hu) CD38-ellenes antitestek a mielóma multiplex kezelésére
SG10201610317VA (en) Antibodies against cd38 for treatment of multiple myeloma